Trial of a minimum doses of L-dopa (0.5 mg/kg/day) on intractable epilepsy associated with tuberous sclerosis.
Uchiyama
A
A
Segawa Neurological Clinic for Children, Tokyo.
Nomura
Y
Y
Segawa
M
M
D000293:Adolescent; D002648:Child; D004305:Dose-Response Relationship, Drug; D004828:Epilepsies, Partial / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D013036:Spasms, Infantile / Q000188:drug therapy*; D013226:Status Epilepticus / Q000188:drug therapy*; D014402:Tuberous Sclerosis / Q000150:complications*
D007980:Levodopa